Potential of liposomes as drug-carriers in cancer chemotherapy: A review S. B. KayeV. J. Richardson General Review Pages: 81 - 85
Chemotherapy in the management of invasive bladder cancer H. BushN. ThatcherR. Barnard General Review Pages: 87 - 96
Mouse and large-animal toxicology studies of twelve antitumor agents: Relevance to starting dose for Phase I clinical trials J. S. PentaM. RozencweigF. M. Muggia Original Articles Pages: 97 - 101
Effective therapy for Burkitt's lymphoma: High-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy Irma RamirezMargaret P. SullivanJ. J. Butler Original Articles Pages: 103 - 109
Vincristine-methotrexate combination chemotherapy and the influence of weight loss on experimental tumour growth J. H. MulderL. M. van Putten Original Articles Pages: 111 - 116
Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia P. J. KearneyP. Ann LightM. G. Mott Original Articles Pages: 117 - 120
Clinical study of hydrazine sulfate in advanced cancer patients E. SpremulliG. L. WamplerW. Regelson Original Articles Pages: 121 - 124
Mathematical model for adriamycin (Doxorubicin) pharmacokinetics S. D. ReichF. SteinbergM. Berman Original Articles Pages: 125 - 131
HPLC determination of rubidazone and metabolites R. HulhovenJ. P. DesagerC. Harvengt Letter to the Editor Pages: 133 - 133